Process and Product Development Subcommittee

Charter

The Process and Product Development Subcommittee strives to:

  • Establish and communicate best practices in Process and Product Development (PPD) as it relates to therapeutic cell based products.
  • Assess emerging cell processing technologies and forecast their impact on the commercialization process.

Click here to view the full charter.

Projects and Objectives

  • Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. Click here to view upcoming webinars.
  • White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase credibility and visibility of the PPD and ISCT. Click here to view the published PPD white papers.
  • ISCT Annual Meeting: The PPD will be actively involved in the organization of the ISCT Annual Meeting. At least one session in the Strategies for Commercialization Track will be organized by this committee.

 

 


 

Committee Chair

 



Dominic Clarke, PhD
Co-Chair
HemaCare
Winston Salem,NC, United States

John Fink, MBA
Co-Chair
Pall Corporation
Boston, MA, United States

 

Committee Members

 

Alireza Abazari, PhD
Lyell Immunopharma
Seattle, WA, United States

Sasha Aleksic, MSc
FUJIFILM Irvine Scientific
Irvine, CA, United States


 
Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute for Regenerative Medicine
Winston-Salem, NC, United States
Hyalker Amaral, MBA
Terumo BCT
Denver, CO, United States
  
Behnam Ahmadian Baghbaderani, PhD
Lonza Walkersville
Walkersville, MD, United States
Harvey Brandwein, PhD
Cook Myosite
Port Washington, NY, United States
   
Christopher Bravery, PhD
Advanced Biologicals Ltd.
London, United Kingdom

Soenke Brunswieck, PhD
Celonic AG
Basel, Switzerland

   
Scott Burger, MD
Advanced Cell & Gene Therapy
Chapel Hill, NC, United States

Shannon Eaker, PhD
GE Healthcare 
Knoxville, TN, United States

   
David Fiorentini, MSc
Biological Industries
Beit-Haemek, Israel

Maya Fuerstenau-Sharp, PhD
Sartorius-Stedim Biotech
Gottingen, Germany

   

Atefeh Ghorbhani, PhD
CCRM
Toronto, ON, Canada

Clive Glover, PhD
Pall Life Sciences
Portsmouth, United Kingdom
   
Heidi Hagen, MS, MBA
Vineti
Seattle, WA, United States
Jack Hench
GE Healthcare
Durham, NC, United States
   
Robert Jones
Cryoport
London, United Kingdom

Ohad Karnieli, PhD, MBA
Adva Biotechnology
Haifa, Israel

   

Christopher Keller
Celularity
Warren, NJ, United States

Julie Kerby, PhD
Cell & Gene Therapy Catapult
London, United Kingdom
   
Crystal Kraft, PhD
West Pharmaceutical Services
Exton, PA, United States
Mark Leonard
Allogene
San Francisco, CA, United States
   
Kara Levine, PhD
MilliporeSigma
Bedford, MA, United States
Lexan Lhu, MSc
PBS Biotech
Cambridge, MA, United States
   
Yonatan Lipsitz, PhD
Sana Therapeutics 
Boston, MA, United States
Katy McGirr, PhD
Cytonome
Bedford,MA, United States
   
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States
Grace O'Connell, PhD
UC Berkeley
Berkely, CA, United States
   
Steve Oh, PhD
ASTAR
Singapore
Jean-Sébastien Parisse
Aseptic Technologies
Gembloux, Belgium

   
Ulrike Rehn, PhD
Thermo Fisher Scientific
Buffalo, NY, United States

Alaina Schlinker, PhD
Fresenius-Kabi
Lake Zurich, IL, United States

   
Michael Scott, PhD
BlueRock Therapeutics
Toronto, ON, Canada

Robert Sassa
WL Gore & Associates
Exton, MD, United States

 
David Smith, PhD
Hitachi Chemical Advanced Therapeutic Solutions (HCATS)
Allendale, NJ, United States

  
 
  

 


Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy